Biblio
Journal Article
Mellqvist U-H, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, et al. Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase III trial. Blood. 2013.
Shamchi SPourhassan, Zadeh MZirakchian, Østergaard B, Kim J, Raynor WY, Khosravi M, Taghvaei R, Nielsen AL, Gerke O, Werner TJ, et al. Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation. Nucl Med Commun. 2019.
Weisel K, Doyen C, Dimopoulos M, Yee A, Lahuerta JJosé, Martin A, Travers K, Druyts E, Toor K, Abildgaard N, et al. A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation. Leuk Lymphoma. 2016:1-9.
]